Total Payments
$2,685
2024 Payments
$22.48
Companies
17
Transactions
143
Medicare Patients
46
Medicare Billing
$4,291
Payment Breakdown by Category
Food & Beverage$2,685 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,685 | 143 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amarin Pharma Inc. | $651.98 | 28 | $0 (2021) |
| GlaxoSmithKline, LLC. | $349.31 | 17 | $0 (2023) |
| Novo Nordisk Inc | $284.72 | 22 | $0 (2021) |
| Amgen Inc. | $271.51 | 21 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $223.50 | 7 | $0 (2021) |
| ABBVIE INC. | $222.88 | 13 | $0 (2022) |
| Nestle HealthCare Nutrition Inc. | $159.96 | 7 | $0 (2021) |
| Lilly USA, LLC | $132.51 | 7 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $86.02 | 6 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $68.43 | 4 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $22.48 | 1 | Hologic Sales and Service, LLC ($22.48) |
| 2023 | $131.66 | 6 | GlaxoSmithKline, LLC. ($131.66) |
| 2022 | $183.16 | 10 | GlaxoSmithKline, LLC. ($126.78) |
| 2021 | $2,348 | 126 | Amarin Pharma Inc. ($651.98) |
All Payment Transactions
143 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/30/2024 | Hologic Sales and Service, LLC | THINPREP 2000 PROCESSOR (Device), APTIMA | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: Diagnostics | ||||||
| 12/20/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: RESPIRATORY | ||||||
| 11/02/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $26.64 | General |
| Category: RESPIRATORY | ||||||
| 09/19/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $28.55 | General |
| Category: RESPIRATORY | ||||||
| 06/14/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: RESPIRATORY | ||||||
| 04/10/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: RESPIRATORY | ||||||
| 03/02/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: RESPIRATORY | ||||||
| 10/21/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: RESPIRATORY | ||||||
| 07/13/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: RESPIRATORY | ||||||
| 06/17/2022 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/13/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: RESPIRATORY | ||||||
| 05/09/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: RESPIRATORY | ||||||
| 04/28/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Gastroenterology | ||||||
| 04/07/2022 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/18/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: RESPIRATORY | ||||||
| 02/09/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: RESPIRATORY | ||||||
| 01/06/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: RESPIRATORY | ||||||
| 10/20/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: Gastroenterology | ||||||
| 10/16/2021 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $28.51 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/14/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Gastroenterology | ||||||
| 09/28/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $9.03 | General |
| Category: Diabetes | ||||||
| 09/15/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: RESPIRATORY | ||||||
| 09/13/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: Diabetes | ||||||
| 09/09/2021 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 46 | 46 | $13,775 | $4,291 |
Total Patients
46
Total Services
46
Medicare Billing
$4,291
Procedure Codes
2
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $10,385 | $3,192 | 30.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $3,390 | $1,098 | 32.4% |
About Sohyun Lim
Sohyun Lim is a Physician Assistant healthcare provider based in Rowland Heights, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/12/2018. The National Provider Identifier (NPI) number assigned to this provider is 1821506775.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sohyun Lim has received a total of $2,685 in payments from pharmaceutical and medical device companies, with $22.48 received in 2024. These payments were reported across 143 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($2,685).
As a Medicare-enrolled provider, Lim has provided services to 46 Medicare beneficiaries, totaling 46 services with total Medicare billing of $4,291. Data is available for 1 year (2023–2023), covering 2 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Other Specialties Physician Assistant
- Location Rowland Heights, CA
- Active Since 01/12/2018
- Last Updated 09/26/2018
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1821506775
Products in Payments
- Vascepa (Drug) $651.98
- Ozempic (Drug) $284.72
- TRELEGY ELLIPTA (Drug) $278.68
- FARXIGA (Drug) $188.80
- ZENPEP (Drug) $159.96
- LINZESS (Drug) $159.16
- Repatha (Biological) $108.64
- EVENITY (Biological) $99.70
- XIFAXAN (Drug) $86.02
- AREXVY (Drug) $70.63
- EMGALITY (Drug) $70.52
- JARDIANCE (Drug) $68.43
- Otezla (Drug) $63.17
- TRULICITY (Drug) $61.99
- NURTEC ODT (Drug) $59.83
- XARELTO (Drug) $52.43
- Linzess (Drug) $44.57
- CREON (Drug) $38.34
- UBRELVY (Drug) $25.38
- THINPREP 2000 PROCESSOR (Device) $22.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.